Search PubMed⌕ Search

Biomedical subjects

G Haag

Publications and source records attributed to G Haag.

At least 19 recordsLinked to original sources
PubMed2001

The effects of homeopathic belladonna 30CH in healthy volunteers -- a randomized, double-blind experiment.

OBJECTIVES: The practice of homeopathy rests on symptoms, which have been produced by medicinal substances in healthy volunteers, often applied at ultramolecular dilutions. It is unknown whether these symptom patterns are due to specific effects or chance fluctuation. METHODS: We tested the hypothesis that a homeopathic substance can bring about symptoms different from observation and placebo in a double-blind, placebo-controlled crossover design with baseline observation. RESULTS: 87 out of 118 healthy volunteers took both placebo and homeopathic belladonna 30CH in random sequence, after a 2-week observation period, and finished the 8-week trial. Apart from an insignificant tendency for subjects to report more symptoms with belladonna (mean number: 27.34), as compared to observation (24.26) or placebo (24.17), there was no indication that subjects reacted differently to homeopathy than to placebo or during baseline. CONCLUSION: There is no indication that belladonna 30CH produces symptoms different from placebo or from no intervention. Symptoms of a homeopathic pathogenetic trial (HPT) are most likely chance fluctuations.

Adult↗
PubMed2001

The long-term effects of homeopathic treatment of chronic headaches: one year follow-up and single case time series analysis.

Little is known about long-term effects of homeopathic treatment. Following a double-blind, placebo controlled trial of classical homeopathy in chronic headaches, we conducted a 1-year observational study of 18 patients following the double-blind phase, and a complete follow-up study of all trial participants. Eighteen patients received free treatment for daily diary data (frequency, intensity, duration of headaches) over the course of 1 y. All patients enrolled in the double-blind study were sent a 6-week headache diary, a follow-up questionnaire, a personality inventory and a complaint list. Eighty-seven, of the original 98 patients enrolled returned questionnaires, 81 returned diaries. There was no additional change from the end of the trial to the one-year follow-up. The improvement seen at the end of the 12-week trial was stable after 1 y. No differential effects according to treatment after the trial could be seen. Patients with no treatment following the trial had the most improvement after 1 y. Five of 18 patients can be counted responders according to ARIMA analysis of single-case time-series. Patients with double diagnoses and longer treatment duration tended to have clearer improvements than the rest of the patients. Approximately 30% of patients in homeopathic treatment will benefit after 1 y of treatment. There is no indication of a specific, or of a delayed effect of homeopathy.

Double-Blind Method↗
PubMed2000

The long-term effects of homeopathic treatment of chronic headaches: 1 year follow up.

Little is known about the long-term effects of homeopathic treatment. Following a double-blind, placebo-controlled trial of classical homeopathy in chronic headaches, we conducted a complete follow-up study of all trial participants. All patients enrolled in the double-blind study were sent a 6-week headache diary, a follow-up questionnaire. Eighty-seven of the original 98 patients enrolled returned questionnaires, 81 returned diaries. There was no additional change from the end of the trial to the 1-year follow up. The improvement seen at the end of the 12-week trial was stable after 1 year. No differential effects according to treatment after the trial could be seen. Patients with no treatment following the trial had the most improvement after 1 year. Approximately 30% of patients in homeopathic treatment will benefit after 1 year of treatment. There is no indication of a specific, or of a delayed effect of homeopathy.

Chronic Disease↗
PubMed2000

Do caffeine-containing analgesics promote dependence? A review and evaluation.

OBJECTIVE: Debates about the suspected association between kidney disease and use of analgesics have led to concern about whether caffeine could stimulate an undesirable overuse of phenacetin-free combined analgesics. A committee was asked to critically review the pertinent literature and to suggest guides for clinical practice and for consideration of international regulatory authorities. PARTICIPANTS: A group of international scientists, jointly selected by the regulatory authorities of Germany, Switzerland, and Austria and the pharmaceutical industry. EVIDENCE: All invited experts evaluated relevant literature and reports and added further information and comments. CONCLUSIONS: Caffeine has a synergistic effectiveness with analgesics. Although caffeine has a dependence potential, the potential is low. Experimental data regarding dependence potential for caffeine alone may not correspond to the conditions in patients with pain. Withdrawal is not likely to cause stimulation or sustainment of analgesic intake. For drug-induced headache, no single or combined analgesic was consistently identified as causative, and no evidence exists for a special role of caffeine. Strong dependence behavior was observed only in patients using phenacetin-containing preparations, coformulated with antipyretics/analgesics and caffeine. This finding may have led to the impression that caffeine stimulates overuse of analgesics. SUMMARY: Although more experimental and long-term data would be desirable to show possible mechanisms of dependence and to offer unequivocal proof of safety, the committee concluded that the available evidence does not support the claim that analgesics coformulated with caffeine, in the absence of phenacetin, stimulate or sustain overuse.

Analgesics↗
PubMed1999

[Management of mental health and primary care. Development and evaluation of a training program based on the PLISSIT approach].

Deficits in current approaches of psychosomatic and psychiatric education for general practitioners are reviewed. A skill-based training was developed in line with the four step counseling approach of the "PLISSIT" approach: The GP helps in first step ("permission") the patient to accept his problem and assesses informations about causing and maintaining factors of his symptomatology. In the second step he should provide information about the disorder and reverse misunderstanding and passivity (Limited Information). The GP's should develop preliminary strategies for change in the third step ("coping strategies", "symptom management", "special suggestions") and preparate the intensive phase of therapy as the last step. First results of the evaluation of the training program are presented demonstrate the effectiveness and acceptance of the education program.

Disease Management↗
PubMed1996

[Homeopathy in headaches. A review].

Homeopathy as an alternative to conventional therapy is becoming increasingly popular. Although interest is rising, little is known about the real effectiveness of homeopathic therapy in headaches. Three studies addressing this question are discussed: an Italian migraine study, the London migraine study and our own, the Munich headache trial. While the first one reported very high effects, the best ones known in the literature, the results of the other two trials do not endorse this first finding. The London trial did not show any effect other than placebo, although a different time trend was reported. The Munich study failed to show any difference between homeopathy and placebo whatsoever. The merits and shortcomings of these studies are discussed. At present, we do not have any evidence that homeopathic therapy has any effect other than a placebo effect. However, this can be very impressive sometimes. We do not know which variables are correlated with placebo effectiveness, and we do not have any data on real-type homeopathy outside a trial setting, as there are no data available.

English Abstract↗
PubMed1995

[Clinical guide scale for the developmental stages of treated autism].

An evolutionary diagram that takes into account the development of personality and its structuring or restructuring was developed thanks to a better understanding of autistic disorders from a psychodynamic point of view through long term psychoanalytic treatment of autistic children. This grid is organised around the major stages of the formation of the bodily ego which autistic children helped us understand better. The construction of space and the capacities of cognitive instrumentation are logically within this line of structuring. These major stages are defined: the first is the "successful" autistic state; the second is the stage where the primary skin is recovered (feeling of a circular envelope); the third is the symbiotic phase which includes vertical splitting then horizontal splitting of the image of the body; finally, the fourth is the phase of individuation/separation into a whole body. At each stage the following are assessed: state of the image of the body, of the gaze, of language, of writing, the autistic symptoms, emotional-relational manifestations, exploration of space and objects, recognition in time, the aggressive behaviours, reactivity to pain and to immune states (somatic and psychosomatic manifestations).

Autistic Disorder↗
PubMed1993

[Compliance problems and behavioral medicine implications in the drug therapy of pain].

Many patients, even cancer patients do not take their medication at all or at the prescribed dose showing thus a form of noncompliance. Reasons for this are manyfold and differ from patient to patient. They may undergo dynamic changes in the course of disease. Experience shows, that compliance is mainly improved when patients have the impression to be responsible for their comportment. This is an important goal in therapy of patients with chronic pain. Of particular importance is therefore the doctor-patient relation, i.e. non-compliance thus always indicates a disturbed doctor-patient relation.

Chronic Disease↗
PubMed1992

Interurban migration and the dynamics of a system of cities: 1. The stochastic framework with an application to the French urban system.

"A stochastic framework for the modelling of interurban migration is presented. The model is an extension of a recently developed master-equation approach to interregional migration. The population dynamics of the French urban system, described by a set of 78 cities, is investigated within the period 1954-82. The importance of synergy effects (self-reinforcing collective effects) as well as socioeconomic macrovariables for the understanding of urban dynamics becomes obvious. A forecasting of urban dynamics...[up to the year 2002 confirms] this result and [gives] further insight into the nested structure of urban systems."

Demography↗
PubMed1987

A dynamic phase transition model for spatial agglomeration processes.

A nonlinear model of population migration is presented in order to provide a dynamic explanation for the formation of metropolitan areas. "In Section 2 the model is introduced in terms of the rate equations for the mean values of the regional population numbers with specifically chosen individual transition rates. Section 3 gives a survey of concepts and results for the convenience of the reader not interested in the details of the mathematical derivations. Section 4 derives the stationary solutions of the rate equations, that is, the equilibria of the system. Section 5 treats the time dependent solutions of the model equations focussing on the exact analytic solutions along so-called symmetry paths. Section 6 analyzes the dynamic stability of the symmetry path solutions and decides which stationary states are unstable and which are stable equilibrium states."

Demography↗